Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.70747861 |
2 | negative regulation of cell killing (GO:0031342) | 5.70747861 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.63200593 |
4 | neutrophil activation involved in immune response (GO:0002283) | 5.38473787 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.37926654 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.14062368 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.14062368 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.14062368 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.14062368 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.14062368 |
11 | modulation by symbiont of host immune response (GO:0052553) | 5.14062368 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69910199 |
13 | microglial cell activation (GO:0001774) | 4.46414100 |
14 | detection of molecule of bacterial origin (GO:0032490) | 4.34690022 |
15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28436422 |
16 | detection of other organism (GO:0098543) | 4.17872623 |
17 | macrophage activation involved in immune response (GO:0002281) | 4.14893689 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.13792831 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10436887 |
20 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.09415325 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.09243985 |
22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.00738036 |
23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.93750791 |
24 | detection of external biotic stimulus (GO:0098581) | 3.93508617 |
25 | regulation of platelet aggregation (GO:0090330) | 3.90574770 |
26 | neutrophil activation (GO:0042119) | 3.87221068 |
27 | detection of bacterium (GO:0016045) | 3.85149664 |
28 | cellular extravasation (GO:0045123) | 3.76562725 |
29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.73107350 |
30 | macrophage activation (GO:0042116) | 3.71142558 |
31 | response to peptidoglycan (GO:0032494) | 3.68384740 |
32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.67742658 |
33 | response to host immune response (GO:0052572) | 3.67742658 |
34 | negative regulation of interleukin-12 production (GO:0032695) | 3.65364531 |
35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.63005941 |
36 | granulocyte activation (GO:0036230) | 3.55417788 |
37 | neutrophil mediated immunity (GO:0002446) | 3.54324766 |
38 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.46479051 |
39 | respiratory burst (GO:0045730) | 3.45976580 |
40 | low-density lipoprotein particle clearance (GO:0034383) | 3.43084088 |
41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.41355675 |
42 | response to host (GO:0075136) | 3.41355675 |
43 | response to host defenses (GO:0052200) | 3.41355675 |
44 | regulation of necroptotic process (GO:0060544) | 3.39867691 |
45 | leukocyte aggregation (GO:0070486) | 3.39527329 |
46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38852706 |
47 | myeloid cell activation involved in immune response (GO:0002275) | 3.38108648 |
48 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.34494208 |
49 | regulation of mast cell degranulation (GO:0043304) | 3.34063152 |
50 | detection of biotic stimulus (GO:0009595) | 3.33857223 |
51 | positive regulation of receptor recycling (GO:0001921) | 3.32916169 |
52 | positive regulation of granulocyte differentiation (GO:0030854) | 3.32506743 |
53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29099476 |
54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27870337 |
55 | response to interleukin-15 (GO:0070672) | 3.25423451 |
56 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.20446159 |
57 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.20293642 |
58 | positive regulation of mast cell activation (GO:0033005) | 3.17128600 |
59 | B cell receptor signaling pathway (GO:0050853) | 3.15082802 |
60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13541510 |
61 | positive regulation of p38MAPK cascade (GO:1900745) | 3.13079250 |
62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.12888980 |
63 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.12373504 |
64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.09694950 |
65 | oxygen transport (GO:0015671) | 3.09679755 |
66 | myeloid leukocyte mediated immunity (GO:0002444) | 3.08287890 |
67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.04826707 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.04497285 |
69 | negative T cell selection (GO:0043383) | 3.03381230 |
70 | pentose-phosphate shunt (GO:0006098) | 3.01640021 |
71 | sequestering of metal ion (GO:0051238) | 3.00029590 |
72 | negative thymic T cell selection (GO:0045060) | 2.98437165 |
73 | regulation of skeletal muscle contraction (GO:0014819) | 2.98081085 |
74 | regulation of leukocyte degranulation (GO:0043300) | 2.97745927 |
75 | positive thymic T cell selection (GO:0045059) | 2.94304327 |
76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93318313 |
77 | positive regulation of B cell differentiation (GO:0045579) | 2.92800738 |
78 | leukocyte degranulation (GO:0043299) | 2.92449025 |
79 | heme biosynthetic process (GO:0006783) | 2.92037336 |
80 | negative regulation of necroptotic process (GO:0060546) | 2.91682613 |
81 | creatine metabolic process (GO:0006600) | 2.90452105 |
82 | hemoglobin metabolic process (GO:0020027) | 2.90415704 |
83 | protein localization to endosome (GO:0036010) | 2.87493206 |
84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87247881 |
85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85999812 |
86 | NADPH regeneration (GO:0006740) | 2.85840030 |
87 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.85292085 |
88 | immunoglobulin mediated immune response (GO:0016064) | 2.85288754 |
89 | desmosome organization (GO:0002934) | 2.84392791 |
90 | cellular response to interleukin-15 (GO:0071350) | 2.82273348 |
91 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.81896454 |
92 | regulation of B cell differentiation (GO:0045577) | 2.81265941 |
93 | negative regulation of fatty acid transport (GO:2000192) | 2.80697217 |
94 | regulation of mast cell activation (GO:0033003) | 2.79733907 |
95 | valine metabolic process (GO:0006573) | 2.77735333 |
96 | dendritic cell migration (GO:0036336) | 2.75856490 |
97 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.74922576 |
98 | regulation of cholesterol storage (GO:0010885) | 2.74516323 |
99 | regulation of regulatory T cell differentiation (GO:0045589) | 2.74132935 |
100 | positive T cell selection (GO:0043368) | 2.74102577 |
101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69506987 |
102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.68418086 |
103 | amyloid precursor protein catabolic process (GO:0042987) | 2.67694594 |
104 | muscle filament sliding (GO:0030049) | 2.67078189 |
105 | actin-myosin filament sliding (GO:0033275) | 2.67078189 |
106 | megakaryocyte development (GO:0035855) | 2.64971027 |
107 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.64400007 |
108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.64304333 |
109 | regulation of p38MAPK cascade (GO:1900744) | 2.63765808 |
110 | myeloid leukocyte activation (GO:0002274) | 2.61931728 |
111 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61326479 |
112 | tetrapyrrole biosynthetic process (GO:0033014) | 2.60839458 |
113 | 4-hydroxyproline metabolic process (GO:0019471) | 2.60639093 |
114 | skin morphogenesis (GO:0043589) | 2.59238803 |
115 | porphyrin-containing compound metabolic process (GO:0006778) | 2.58652970 |
116 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.58087327 |
117 | type I interferon signaling pathway (GO:0060337) | 2.57671060 |
118 | cellular response to type I interferon (GO:0071357) | 2.57671060 |
119 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.57623253 |
120 | apoptotic cell clearance (GO:0043277) | 2.57113249 |
121 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56674876 |
122 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56674876 |
123 | response to laminar fluid shear stress (GO:0034616) | 2.55935754 |
124 | T cell selection (GO:0045058) | 2.55894551 |
125 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55077294 |
126 | response to type I interferon (GO:0034340) | 2.54860139 |
127 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.53964610 |
128 | sulfur amino acid catabolic process (GO:0000098) | 2.52307912 |
129 | adhesion of symbiont to host (GO:0044406) | 2.51474368 |
130 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49116959 |
131 | regulation of sequestering of triglyceride (GO:0010889) | 2.47831520 |
132 | positive regulation of nuclease activity (GO:0032075) | 2.47772932 |
133 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.46418166 |
134 | sarcomere organization (GO:0045214) | 2.45464445 |
135 | maternal placenta development (GO:0001893) | 2.45417686 |
136 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.44867157 |
137 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.43106236 |
138 | fatty acid beta-oxidation (GO:0006635) | 2.42471191 |
139 | NADP metabolic process (GO:0006739) | 2.41830625 |
140 | heme metabolic process (GO:0042168) | 2.40841068 |
141 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.40435866 |
142 | epithelial cell-cell adhesion (GO:0090136) | 2.39858307 |
143 | rhodopsin mediated signaling pathway (GO:0016056) | 2.38738732 |
144 | response to arsenic-containing substance (GO:0046685) | 2.37663773 |
145 | cellular response to unfolded protein (GO:0034620) | 2.36643203 |
146 | adhesion of symbiont to host cell (GO:0044650) | 2.35257305 |
147 | virion attachment to host cell (GO:0019062) | 2.35257305 |
148 | Golgi transport vesicle coating (GO:0048200) | 2.35226450 |
149 | COPI coating of Golgi vesicle (GO:0048205) | 2.35226450 |
150 | hemidesmosome assembly (GO:0031581) | 2.33564320 |
151 | endodermal cell differentiation (GO:0035987) | 2.33186452 |
152 | ER-nucleus signaling pathway (GO:0006984) | 2.32208253 |
153 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.31302530 |
154 | ethanol oxidation (GO:0006069) | 2.30906389 |
155 | fatty acid transmembrane transport (GO:1902001) | 2.29996677 |
156 | basement membrane organization (GO:0071711) | 2.29477028 |
157 | response to methylmercury (GO:0051597) | 2.29263057 |
158 | hepatocyte apoptotic process (GO:0097284) | 2.27694202 |
159 | cell adhesion mediated by integrin (GO:0033627) | 2.26675566 |
160 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.26419131 |
161 | glucose catabolic process (GO:0006007) | 2.25643016 |
162 | mannose metabolic process (GO:0006013) | 2.24485238 |
163 | cysteine metabolic process (GO:0006534) | 2.24100933 |
164 | surfactant homeostasis (GO:0043129) | 2.23295268 |
165 | carnitine shuttle (GO:0006853) | 2.22756016 |
166 | regulation of nuclease activity (GO:0032069) | 2.21799560 |
167 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.21521509 |
168 | antimicrobial humoral response (GO:0019730) | 2.21402841 |
169 | atrioventricular valve morphogenesis (GO:0003181) | 2.21372405 |
170 | membrane raft organization (GO:0031579) | 2.20754315 |
171 | lysine catabolic process (GO:0006554) | 2.19966524 |
172 | lysine metabolic process (GO:0006553) | 2.19966524 |
173 | plasma lipoprotein particle clearance (GO:0034381) | 2.19763745 |
174 | barbed-end actin filament capping (GO:0051016) | 2.19685901 |
175 | cellular response to topologically incorrect protein (GO:0035967) | 2.19478173 |
176 | ethanol metabolic process (GO:0006067) | 2.19081653 |
177 | antibacterial humoral response (GO:0019731) | 2.18431926 |
178 | actin-mediated cell contraction (GO:0070252) | 2.18296885 |
179 | positive regulation of fatty acid oxidation (GO:0046321) | 2.18200491 |
180 | growth hormone receptor signaling pathway (GO:0060396) | 2.18030503 |
181 | regulation of cholesterol homeostasis (GO:2000188) | 2.17146632 |
182 | membrane protein ectodomain proteolysis (GO:0006509) | 2.17070225 |
183 | cellular response to arsenic-containing substance (GO:0071243) | 2.16990672 |
184 | myelin maintenance (GO:0043217) | 2.16790649 |
185 | * fatty acid oxidation (GO:0019395) | 2.16596961 |
186 | protein retention in ER lumen (GO:0006621) | 2.16447329 |
187 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.14822552 |
188 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.14197919 |
189 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.13693909 |
190 | regulation of triglyceride catabolic process (GO:0010896) | 2.13373570 |
191 | * lipid oxidation (GO:0034440) | 2.12657408 |
192 | alpha-linolenic acid metabolic process (GO:0036109) | 2.11651042 |
193 | iron ion import (GO:0097286) | 2.10880952 |
194 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.10138965 |
195 | regulation of cholesterol metabolic process (GO:0090181) | 2.09002820 |
196 | protein-lipid complex assembly (GO:0065005) | 2.08491200 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.83215803 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58913744 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37819324 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.29491899 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.29082791 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.79343840 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.69770019 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67912710 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57139930 |
10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.55968122 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.54994174 |
12 | SPI1_23127762_ChIP-Seq_K562_Human | 2.49024167 |
13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45833336 |
14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.44814518 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.44725455 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.43799522 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41669119 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36420722 |
19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.35600593 |
20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.26355696 |
21 | MYB_26560356_Chip-Seq_TH2_Human | 2.25493047 |
22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24566361 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21534960 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.11531924 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04917419 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.04034379 |
27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02168973 |
28 | MYB_26560356_Chip-Seq_TH1_Human | 2.00432692 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98329694 |
30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95023080 |
31 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90608245 |
32 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.86008505 |
33 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80663233 |
34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.80490791 |
35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.75281719 |
36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75228308 |
37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72753899 |
38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70467170 |
39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.70325099 |
40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68488322 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68098354 |
42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63312366 |
43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.60169530 |
44 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60096857 |
45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59266949 |
46 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57395224 |
47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56480386 |
48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55226946 |
49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54930668 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54279603 |
51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54262266 |
52 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.54174025 |
53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53950421 |
54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52394193 |
55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51748942 |
56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51129931 |
57 | MAF_26560356_Chip-Seq_TH2_Human | 1.48976049 |
58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48867852 |
59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46584435 |
60 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.45165614 |
61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44601594 |
62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44134982 |
63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43534590 |
64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.42572993 |
65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42003524 |
66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40290411 |
67 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40197093 |
68 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38135247 |
69 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37948981 |
70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36666628 |
71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36441243 |
72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36211654 |
73 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.34365315 |
74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34167168 |
75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34002551 |
76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33025547 |
77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.32854756 |
78 | MAF_26560356_Chip-Seq_TH1_Human | 1.32693679 |
79 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32298022 |
80 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31803673 |
81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31452378 |
82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30111931 |
83 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28011746 |
84 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27599910 |
85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27252942 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25391986 |
87 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.24932518 |
88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24276094 |
89 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24234505 |
90 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24234505 |
91 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23806678 |
92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23665383 |
93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23444556 |
94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21713317 |
95 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.21600431 |
96 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20891239 |
97 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18881154 |
98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18881154 |
99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17525818 |
100 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.16375856 |
101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16013808 |
102 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15346255 |
103 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15341173 |
104 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14926104 |
105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14127439 |
106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13443185 |
107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12634589 |
108 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12423855 |
109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12146940 |
110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11775217 |
111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11679796 |
112 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11366577 |
113 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10846143 |
114 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10412898 |
115 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10281842 |
116 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09448390 |
117 | MYC_22102868_ChIP-Seq_BL_Human | 1.08283230 |
118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08029728 |
119 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07287458 |
120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07148122 |
121 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06584230 |
122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05460222 |
123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05198098 |
124 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05176778 |
125 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04356231 |
126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03045538 |
127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01892370 |
128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01145335 |
129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00953542 |
130 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00601299 |
131 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00522972 |
132 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.99561537 |
133 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98787415 |
134 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98776245 |
135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98332687 |
136 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98324471 |
137 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98152785 |
138 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96588495 |
139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96429601 |
140 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95541981 |
141 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95479166 |
142 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94425606 |
143 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93865829 |
144 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93774252 |
145 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93728662 |
146 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92776663 |
147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92619347 |
148 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92400996 |
149 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91562146 |
150 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91442334 |
151 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91220052 |
152 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89910578 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.08258118 |
2 | MP0003656_abnormal_erythrocyte_physiolo | 2.82482077 |
3 | MP0003705_abnormal_hypodermis_morpholog | 2.80631264 |
4 | MP0003011_delayed_dark_adaptation | 2.73050352 |
5 | MP0005451_abnormal_body_composition | 2.57053771 |
6 | MP0005058_abnormal_lysosome_morphology | 2.52975263 |
7 | MP0008438_abnormal_cutaneous_collagen | 2.44156031 |
8 | MP0005025_abnormal_response_to | 2.31247001 |
9 | MP0001800_abnormal_humoral_immune | 2.30389085 |
10 | MP0003763_abnormal_thymus_physiology | 2.22727886 |
11 | MP0009840_abnormal_foam_cell | 2.22680615 |
12 | MP0005000_abnormal_immune_tolerance | 2.21631089 |
13 | MP0003172_abnormal_lysosome_physiology | 2.20309356 |
14 | MP0000685_abnormal_immune_system | 2.20247107 |
15 | MP0004381_abnormal_hair_follicle | 2.18200520 |
16 | MP0009785_altered_susceptibility_to | 2.16285174 |
17 | MP0005671_abnormal_response_to | 2.15324120 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.10147111 |
19 | MP0002723_abnormal_immune_serum | 2.07102617 |
20 | MP0002420_abnormal_adaptive_immunity | 2.05801762 |
21 | MP0001819_abnormal_immune_cell | 2.03528434 |
22 | MP0002452_abnormal_antigen_presenting | 2.01051275 |
23 | MP0005275_abnormal_skin_tensile | 2.00263930 |
24 | MP0002837_dystrophic_cardiac_calcinosis | 1.98895055 |
25 | MP0003950_abnormal_plasma_membrane | 1.97284997 |
26 | MP0002132_abnormal_respiratory_system | 1.96657239 |
27 | MP0001790_abnormal_immune_system | 1.96152432 |
28 | MP0005387_immune_system_phenotype | 1.96152432 |
29 | MP0002398_abnormal_bone_marrow | 1.90742213 |
30 | MP0003806_abnormal_nucleotide_metabolis | 1.84346117 |
31 | MP0002148_abnormal_hypersensitivity_rea | 1.84241374 |
32 | MP0003566_abnormal_cell_adhesion | 1.81841753 |
33 | MP0006082_CNS_inflammation | 1.77587559 |
34 | MP0005083_abnormal_biliary_tract | 1.75833428 |
35 | MP0004147_increased_porphyrin_level | 1.75657635 |
36 | MP0002877_abnormal_melanocyte_morpholog | 1.72783283 |
37 | MP0004185_abnormal_adipocyte_glucose | 1.72641395 |
38 | MP0000569_abnormal_digit_pigmentation | 1.70343311 |
39 | MP0003300_gastrointestinal_ulcer | 1.69482531 |
40 | MP0000716_abnormal_immune_system | 1.64235962 |
41 | MP0000015_abnormal_ear_pigmentation | 1.61003139 |
42 | MP0003436_decreased_susceptibility_to | 1.60438316 |
43 | MP0004883_abnormal_blood_vessel | 1.60148991 |
44 | MP0002722_abnormal_immune_system | 1.59660054 |
45 | MP0000689_abnormal_spleen_morphology | 1.58649630 |
46 | MP0010155_abnormal_intestine_physiology | 1.55122027 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.54788098 |
48 | MP0002139_abnormal_hepatobiliary_system | 1.54280175 |
49 | MP0003866_abnormal_defecation | 1.51561987 |
50 | MP0001845_abnormal_inflammatory_respons | 1.50412955 |
51 | MP0001851_eye_inflammation | 1.48203441 |
52 | MP0004084_abnormal_cardiac_muscle | 1.48084995 |
53 | MP0010234_abnormal_vibrissa_follicle | 1.47541800 |
54 | MP0000343_altered_response_to | 1.47342250 |
55 | MP0002429_abnormal_blood_cell | 1.47126603 |
56 | MP0005075_abnormal_melanosome_morpholog | 1.46836915 |
57 | MP0006054_spinal_hemorrhage | 1.44543773 |
58 | MP0000703_abnormal_thymus_morphology | 1.41325296 |
59 | MP0003279_aneurysm | 1.41299270 |
60 | MP0000750_abnormal_muscle_regeneration | 1.39966566 |
61 | MP0003303_peritoneal_inflammation | 1.39956755 |
62 | MP0002796_impaired_skin_barrier | 1.39499716 |
63 | MP0003453_abnormal_keratinocyte_physiol | 1.36638303 |
64 | MP0010352_gastrointestinal_tract_polyps | 1.35073710 |
65 | MP0008004_abnormal_stomach_pH | 1.33677281 |
66 | MP0000465_gastrointestinal_hemorrhage | 1.32032446 |
67 | MP0003183_abnormal_peptide_metabolism | 1.31789721 |
68 | MP0009278_abnormal_bone_marrow | 1.30456377 |
69 | MP0005666_abnormal_adipose_tissue | 1.30142199 |
70 | MP0005310_abnormal_salivary_gland | 1.29861886 |
71 | MP0005023_abnormal_wound_healing | 1.29234422 |
72 | MP0000749_muscle_degeneration | 1.29135985 |
73 | MP0004272_abnormal_basement_membrane | 1.29111454 |
74 | MP0002396_abnormal_hematopoietic_system | 1.27171941 |
75 | MP0005164_abnormal_response_to | 1.26472308 |
76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25136550 |
77 | MP0004130_abnormal_muscle_cell | 1.23473231 |
78 | MP0001958_emphysema | 1.23255355 |
79 | MP0005501_abnormal_skin_physiology | 1.22419113 |
80 | MP0004087_abnormal_muscle_fiber | 1.20941746 |
81 | MP0001533_abnormal_skeleton_physiology | 1.20870314 |
82 | MP0003724_increased_susceptibility_to | 1.20288055 |
83 | MP0004036_abnormal_muscle_relaxation | 1.19420953 |
84 | MP0001666_abnormal_nutrient_absorption | 1.17588753 |
85 | MP0002166_altered_tumor_susceptibility | 1.11414861 |
86 | MP0002060_abnormal_skin_morphology | 1.11406661 |
87 | MP0004808_abnormal_hematopoietic_stem | 1.09094356 |
88 | MP0003075_altered_response_to | 1.08751613 |
89 | MP0005330_cardiomyopathy | 1.08747923 |
90 | MP0003828_pulmonary_edema | 1.08467416 |
91 | MP0005076_abnormal_cell_differentiation | 1.07513592 |
92 | MP0004947_skin_inflammation | 1.07343543 |
93 | MP0004510_myositis | 1.06286725 |
94 | MP0010368_abnormal_lymphatic_system | 1.05123979 |
95 | MP0000733_abnormal_muscle_development | 1.04588720 |
96 | * MP0000609_abnormal_liver_physiology | 1.04537388 |
97 | MP0002998_abnormal_bone_remodeling | 1.04134037 |
98 | MP0000747_muscle_weakness | 1.04026980 |
99 | * MP0003186_abnormal_redox_activity | 1.03462250 |
100 | MP0005375_adipose_tissue_phenotype | 1.03180596 |
101 | MP0009763_increased_sensitivity_to | 1.01484268 |
102 | MP0010630_abnormal_cardiac_muscle | 1.01326176 |
103 | MP0009643_abnormal_urine_homeostasis | 1.01003335 |
104 | MP0005365_abnormal_bile_salt | 0.96688606 |
105 | MP0009384_cardiac_valve_regurgitation | 0.96558771 |
106 | MP0000858_altered_metastatic_potential | 0.95187172 |
107 | MP0005464_abnormal_platelet_physiology | 0.94854827 |
108 | MP0005360_urolithiasis | 0.93031147 |
109 | MP0005174_abnormal_tail_pigmentation | 0.89989443 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.89462221 |
111 | MP0010329_abnormal_lipoprotein_level | 0.88298530 |
112 | MP0005397_hematopoietic_system_phenotyp | 0.88041021 |
113 | MP0001545_abnormal_hematopoietic_system | 0.88041021 |
114 | MP0002972_abnormal_cardiac_muscle | 0.87200797 |
115 | MP0008874_decreased_physiological_sensi | 0.87170888 |
116 | MP0001216_abnormal_epidermal_layer | 0.86713416 |
117 | MP0005551_abnormal_eye_electrophysiolog | 0.86478323 |
118 | MP0008260_abnormal_autophagy | 0.86165218 |
119 | MP0009765_abnormal_xenobiotic_induced | 0.85961475 |
120 | MP0000604_amyloidosis | 0.82639510 |
121 | MP0005670_abnormal_white_adipose | 0.82174010 |
122 | MP0009764_decreased_sensitivity_to | 0.81983935 |
123 | MP0003690_abnormal_glial_cell | 0.81746198 |
124 | * MP0000759_abnormal_skeletal_muscle | 0.81043372 |
125 | MP0000751_myopathy | 0.80846961 |
126 | MP0003091_abnormal_cell_migration | 0.80798555 |
127 | MP0005620_abnormal_muscle_contractility | 0.80714865 |
128 | MP0001663_abnormal_digestive_system | 0.79712337 |
129 | MP0002419_abnormal_innate_immunity | 0.79448403 |
130 | MP0002295_abnormal_pulmonary_circulatio | 0.79159358 |
131 | * MP0002118_abnormal_lipid_homeostasis | 0.78552117 |
132 | MP0000767_abnormal_smooth_muscle | 0.77947622 |
133 | MP0001544_abnormal_cardiovascular_syste | 0.77247381 |
134 | MP0005385_cardiovascular_system_phenoty | 0.77247381 |
135 | MP0004484_altered_response_of | 0.77153622 |
136 | MP0005253_abnormal_eye_physiology | 0.76382578 |
137 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75787454 |
138 | MP0000249_abnormal_blood_vessel | 0.75684835 |
139 | MP0002138_abnormal_hepatobiliary_system | 0.75640274 |
140 | MP0002269_muscular_atrophy | 0.75121982 |
141 | MP0001879_abnormal_lymphatic_vessel | 0.74966823 |
142 | MP0009931_abnormal_skin_appearance | 0.74891504 |
143 | MP0004782_abnormal_surfactant_physiolog | 0.74049367 |
144 | MP0005085_abnormal_gallbladder_physiolo | 0.74039089 |
145 | MP0002006_tumorigenesis | 0.73868112 |
146 | MP0005167_abnormal_blood-brain_barrier | 0.73319300 |
147 | MP0005166_decreased_susceptibility_to | 0.73221341 |
148 | MP0002090_abnormal_vision | 0.73180127 |
149 | MP0004019_abnormal_vitamin_homeostasis | 0.72811181 |
150 | MP0005636_abnormal_mineral_homeostasis | 0.72708637 |
151 | MP0010678_abnormal_skin_adnexa | 0.72360222 |
152 | MP0002405_respiratory_system_inflammati | 0.71995354 |
153 | MP0005165_increased_susceptibility_to | 0.71759909 |
154 | MP0003448_altered_tumor_morphology | 0.71388422 |
155 | MP0002098_abnormal_vibrissa_morphology | 0.70896834 |
156 | MP0008469_abnormal_protein_level | 0.70499604 |
157 | MP0001243_abnormal_dermal_layer | 0.70418514 |
158 | MP0002019_abnormal_tumor_incidence | 0.70104460 |
159 | MP0005621_abnormal_cell_physiology | 0.70031423 |
160 | MP0000371_diluted_coat_color | 0.69987170 |
161 | MP0001853_heart_inflammation | 0.65090941 |
162 | MP0003795_abnormal_bone_structure | 0.64858802 |
163 | MP0003329_amyloid_beta_deposits | 0.63277567 |
164 | MP0002277_abnormal_respiratory_mucosa | 0.62619581 |
165 | MP0000490_abnormal_crypts_of | 0.61064177 |
166 | MP0004264_abnormal_extraembryonic_tissu | 0.60490904 |
167 | MP0003045_fibrosis | 0.56092329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 5.45472886 |
2 | Hypochromic microcytic anemia (HP:0004840) | 5.26868361 |
3 | Recurrent abscess formation (HP:0002722) | 5.23933616 |
4 | Prolonged bleeding time (HP:0003010) | 4.95793756 |
5 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.72161660 |
6 | Gingival bleeding (HP:0000225) | 4.47090239 |
7 | Myositis (HP:0100614) | 4.21838717 |
8 | Epistaxis (HP:0000421) | 3.98496820 |
9 | Orchitis (HP:0100796) | 3.96876556 |
10 | Petechiae (HP:0000967) | 3.93425005 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.79945887 |
12 | Gastrointestinal infarctions (HP:0005244) | 3.76890049 |
13 | Abnormal platelet volume (HP:0011876) | 3.75968362 |
14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.74455305 |
15 | Retrobulbar optic neuritis (HP:0100654) | 3.70837380 |
16 | Optic neuritis (HP:0100653) | 3.70837380 |
17 | T lymphocytopenia (HP:0005403) | 3.69603422 |
18 | Stomatitis (HP:0010280) | 3.69362613 |
19 | Right ventricular cardiomyopathy (HP:0011663) | 3.50669162 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47922773 |
21 | Hypochromic anemia (HP:0001931) | 3.44867232 |
22 | Purpura (HP:0000979) | 3.41746495 |
23 | Muscle fiber splitting (HP:0003555) | 3.41589871 |
24 | Recurrent fungal infections (HP:0002841) | 3.40728613 |
25 | Obstructive lung disease (HP:0006536) | 3.38819291 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38819291 |
27 | Increased mean platelet volume (HP:0011877) | 3.37519929 |
28 | Abnormality of T cell number (HP:0011839) | 3.36838572 |
29 | Hyporeflexia of lower limbs (HP:0002600) | 3.34616796 |
30 | Menorrhagia (HP:0000132) | 3.31463534 |
31 | Exercise-induced muscle cramps (HP:0003710) | 3.31393123 |
32 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.30345362 |
33 | Recurrent skin infections (HP:0001581) | 3.29655885 |
34 | Gingivitis (HP:0000230) | 3.22483205 |
35 | Slow saccadic eye movements (HP:0000514) | 3.12124682 |
36 | Increased cerebral lipofuscin (HP:0011813) | 3.06379934 |
37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01951659 |
38 | Congenital stationary night blindness (HP:0007642) | 2.98103275 |
39 | Poikilocytosis (HP:0004447) | 2.94388537 |
40 | Arterial thrombosis (HP:0004420) | 2.87296886 |
41 | Mediastinal lymphadenopathy (HP:0100721) | 2.87057345 |
42 | Increased connective tissue (HP:0009025) | 2.85715948 |
43 | Keratoconjunctivitis sicca (HP:0001097) | 2.83415959 |
44 | Ventricular tachycardia (HP:0004756) | 2.82625914 |
45 | Pigmentary retinal degeneration (HP:0001146) | 2.80582403 |
46 | Premature rupture of membranes (HP:0001788) | 2.80023796 |
47 | Meningitis (HP:0001287) | 2.74643047 |
48 | Myoglobinuria (HP:0002913) | 2.74485537 |
49 | Encephalitis (HP:0002383) | 2.73053536 |
50 | Vacuolated lymphocytes (HP:0001922) | 2.71820253 |
51 | Exercise-induced myalgia (HP:0003738) | 2.71175012 |
52 | Central scotoma (HP:0000603) | 2.70378009 |
53 | Chest pain (HP:0100749) | 2.69789086 |
54 | Asymmetric septal hypertrophy (HP:0001670) | 2.65945254 |
55 | Increased IgE level (HP:0003212) | 2.64135395 |
56 | Recurrent viral infections (HP:0004429) | 2.61545002 |
57 | Dysostosis multiplex (HP:0000943) | 2.59847667 |
58 | Vasculitis (HP:0002633) | 2.58599105 |
59 | Inflammation of the large intestine (HP:0002037) | 2.55668828 |
60 | Cellulitis (HP:0100658) | 2.55578850 |
61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54650494 |
62 | Episodic fever (HP:0001954) | 2.54580409 |
63 | Muscle fiber inclusion bodies (HP:0100299) | 2.54427114 |
64 | Keratoconjunctivitis (HP:0001096) | 2.53194782 |
65 | Type 1 muscle fiber predominance (HP:0003803) | 2.52166132 |
66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.51912318 |
67 | Leukocytosis (HP:0001974) | 2.51637563 |
68 | Anorexia (HP:0002039) | 2.51275250 |
69 | Gastrointestinal inflammation (HP:0004386) | 2.51124654 |
70 | Interstitial pulmonary disease (HP:0006530) | 2.50881383 |
71 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.50774481 |
72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45566276 |
73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45566276 |
74 | Rhabdomyolysis (HP:0003201) | 2.45373356 |
75 | Difficulty running (HP:0009046) | 2.44341501 |
76 | Abnormality of T cells (HP:0002843) | 2.43604579 |
77 | Conjunctival hamartoma (HP:0100780) | 2.41100586 |
78 | Scotoma (HP:0000575) | 2.39074223 |
79 | Distal arthrogryposis (HP:0005684) | 2.38768269 |
80 | Xanthomatosis (HP:0000991) | 2.37208530 |
81 | Polycythemia (HP:0001901) | 2.35783950 |
82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34243249 |
83 | Osteolytic defects of the hand bones (HP:0009699) | 2.34243249 |
84 | Cholelithiasis (HP:0001081) | 2.32996108 |
85 | Abolished electroretinogram (ERG) (HP:0000550) | 2.31380668 |
86 | Abnormal platelet function (HP:0011869) | 2.29271472 |
87 | Impaired platelet aggregation (HP:0003540) | 2.29271472 |
88 | Hypoglycemic coma (HP:0001325) | 2.29244361 |
89 | Granulocytopenia (HP:0001913) | 2.27144912 |
90 | Ulnar deviation of the wrist (HP:0003049) | 2.26597276 |
91 | Orthostatic hypotension (HP:0001278) | 2.26500443 |
92 | Difficulty climbing stairs (HP:0003551) | 2.26344742 |
93 | Round ear (HP:0100830) | 2.25609463 |
94 | Hematochezia (HP:0002573) | 2.25026885 |
95 | Protrusio acetabuli (HP:0003179) | 2.24813954 |
96 | Visual hallucinations (HP:0002367) | 2.23272104 |
97 | Chorioretinal atrophy (HP:0000533) | 2.22729442 |
98 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.22329110 |
99 | Abnormal gallbladder morphology (HP:0012437) | 2.19399913 |
100 | Acute hepatic failure (HP:0006554) | 2.18317430 |
101 | Eczematoid dermatitis (HP:0000976) | 2.18032691 |
102 | Deep venous thrombosis (HP:0002625) | 2.17691629 |
103 | Reticulocytosis (HP:0001923) | 2.17668537 |
104 | Pulmonary embolism (HP:0002204) | 2.16521136 |
105 | Osteomyelitis (HP:0002754) | 2.16055781 |
106 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15989278 |
107 | Nemaline bodies (HP:0003798) | 2.15883486 |
108 | Abnormal gallbladder physiology (HP:0012438) | 2.14466121 |
109 | Cholecystitis (HP:0001082) | 2.14466121 |
110 | Distal lower limb muscle weakness (HP:0009053) | 2.14365555 |
111 | Increased serum ferritin (HP:0003281) | 2.13571053 |
112 | Muscle stiffness (HP:0003552) | 2.11276700 |
113 | Pustule (HP:0200039) | 2.10898130 |
114 | Myopathic facies (HP:0002058) | 2.10146408 |
115 | Axonal loss (HP:0003447) | 2.09482218 |
116 | Hemoptysis (HP:0002105) | 2.08290051 |
117 | Sudden death (HP:0001699) | 2.06766382 |
118 | Cerebral aneurysm (HP:0004944) | 2.06360753 |
119 | Amyloidosis (HP:0011034) | 2.05993016 |
120 | Peritonitis (HP:0002586) | 2.05532255 |
121 | Aortic aneurysm (HP:0004942) | 2.05055408 |
122 | Bruising susceptibility (HP:0000978) | 2.04847956 |
123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04762662 |
124 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.03648344 |
125 | Subacute progressive viral hepatitis (HP:0006572) | 2.03391400 |
126 | Myocardial infarction (HP:0001658) | 2.03156686 |
127 | Autoimmune hemolytic anemia (HP:0001890) | 2.03058624 |
128 | Postural instability (HP:0002172) | 2.02779550 |
129 | Conjunctival telangiectasia (HP:0000524) | 2.02706627 |
130 | Paralysis (HP:0003470) | 2.01507571 |
131 | EMG: myopathic abnormalities (HP:0003458) | 2.01476597 |
132 | Hypoalphalipoproteinemia (HP:0003233) | 2.01407850 |
133 | Abnormality of macular pigmentation (HP:0008002) | 2.00853700 |
134 | Fatigue (HP:0012378) | 1.98458233 |
135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98095719 |
136 | Colitis (HP:0002583) | 1.96485118 |
137 | Abnormality of iron homeostasis (HP:0011031) | 1.96273710 |
138 | Pulmonary infiltrates (HP:0002113) | 1.95336858 |
139 | Toxemia of pregnancy (HP:0100603) | 1.95299533 |
140 | Urticaria (HP:0001025) | 1.94712097 |
141 | Cone-rod dystrophy (HP:0000548) | 1.94480377 |
142 | Diaphragmatic weakness (HP:0009113) | 1.94341044 |
143 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93463225 |
144 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93463225 |
145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93463225 |
146 | Palpitations (HP:0001962) | 1.93365531 |
147 | Hepatosplenomegaly (HP:0001433) | 1.92550615 |
148 | Increased IgM level (HP:0003496) | 1.91031770 |
149 | Flat acetabular roof (HP:0003180) | 1.90793533 |
150 | Gangrene (HP:0100758) | 1.90576957 |
151 | Progressive visual loss (HP:0000529) | 1.89927743 |
152 | Fragile skin (HP:0001030) | 1.89870930 |
153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89644249 |
154 | Mucopolysacchariduria (HP:0008155) | 1.89644249 |
155 | Abnormality of macrophages (HP:0004311) | 1.89251569 |
156 | Eosinophilia (HP:0001880) | 1.88571295 |
157 | Abnormality of the peritoneum (HP:0002585) | 1.88487654 |
158 | Lipoatrophy (HP:0100578) | 1.87787633 |
159 | Stridor (HP:0010307) | 1.86639175 |
160 | Dysautonomia (HP:0002459) | 1.85798450 |
161 | Facial diplegia (HP:0001349) | 1.85242064 |
162 | Short nail (HP:0001799) | 1.84287860 |
163 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83448784 |
164 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81835675 |
165 | Cerebral inclusion bodies (HP:0100314) | 1.81789339 |
166 | Skin ulcer (HP:0200042) | 1.80673777 |
167 | Viral hepatitis (HP:0006562) | 1.79991242 |
168 | Retinal atrophy (HP:0001105) | 1.78326484 |
169 | Beaking of vertebral bodies (HP:0004568) | 1.78251654 |
170 | Dyschromatopsia (HP:0007641) | 1.77753500 |
171 | Acanthosis nigricans (HP:0000956) | 1.76793829 |
172 | Esophageal varix (HP:0002040) | 1.76441024 |
173 | Vertebral compression fractures (HP:0002953) | 1.74757006 |
174 | Systemic lupus erythematosus (HP:0002725) | 1.74754994 |
175 | Hand muscle atrophy (HP:0009130) | 1.73747919 |
176 | Spinal rigidity (HP:0003306) | 1.73414805 |
177 | Distal upper limb amyotrophy (HP:0007149) | 1.73409520 |
178 | Upper limb amyotrophy (HP:0009129) | 1.73409520 |
179 | Acanthocytosis (HP:0001927) | 1.73102772 |
180 | Nonimmune hydrops fetalis (HP:0001790) | 1.72535677 |
181 | Dilated cardiomyopathy (HP:0001644) | 1.72277074 |
182 | Metaphyseal cupping (HP:0003021) | 1.68837085 |
183 | Microcytic anemia (HP:0001935) | 1.68157866 |
184 | Spontaneous hematomas (HP:0007420) | 1.67491174 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.68318678 |
2 | TRIB3 | 4.32535180 |
3 | ERN1 | 3.19659518 |
4 | TTN | 2.89431487 |
5 | PKN2 | 2.76949528 |
6 | FGR | 2.62919293 |
7 | EPHB1 | 2.45982243 |
8 | IRAK4 | 2.41213220 |
9 | MAP4K1 | 2.38078297 |
10 | TGFBR2 | 2.24002716 |
11 | TAOK1 | 2.18939786 |
12 | BCKDK | 2.05206285 |
13 | FES | 2.02026230 |
14 | MAP3K3 | 1.98109251 |
15 | STK10 | 1.89568731 |
16 | MAPKAPK3 | 1.87529400 |
17 | LRRK2 | 1.86020688 |
18 | PTK2B | 1.76910133 |
19 | IKBKE | 1.76047102 |
20 | TAOK2 | 1.75628277 |
21 | MAP2K3 | 1.74436107 |
22 | PRPF4B | 1.72244659 |
23 | SYK | 1.71874364 |
24 | KDR | 1.70713018 |
25 | PTK6 | 1.67417484 |
26 | TRPM7 | 1.66636059 |
27 | PIK3CG | 1.59425741 |
28 | HCK | 1.58280662 |
29 | MAP3K1 | 1.56089656 |
30 | MAP2K2 | 1.48081632 |
31 | SIK1 | 1.44902587 |
32 | BMPR2 | 1.40561152 |
33 | EPHA2 | 1.40293673 |
34 | TAOK3 | 1.37611235 |
35 | GRK5 | 1.35732772 |
36 | PIM2 | 1.35684923 |
37 | TXK | 1.34329320 |
38 | KSR2 | 1.32020777 |
39 | EEF2K | 1.30683542 |
40 | MET | 1.30436671 |
41 | MAP3K14 | 1.28789972 |
42 | TBK1 | 1.26431801 |
43 | TNK2 | 1.21632934 |
44 | TYK2 | 1.21048500 |
45 | GRK1 | 1.19257616 |
46 | PBK | 1.17189629 |
47 | DMPK | 1.15832864 |
48 | DYRK1B | 1.15226953 |
49 | LYN | 1.11833228 |
50 | PTK2 | 1.09958326 |
51 | MAP3K10 | 1.09947120 |
52 | NEK9 | 1.09250995 |
53 | FGFR4 | 1.06536057 |
54 | RIPK1 | 1.05626532 |
55 | RPS6KA4 | 1.04418658 |
56 | OBSCN | 1.02082335 |
57 | YES1 | 1.01094292 |
58 | TESK2 | 1.00048066 |
59 | IRAK1 | 0.99965638 |
60 | TEC | 0.99007000 |
61 | MAP3K11 | 0.98453224 |
62 | STK4 | 0.98282984 |
63 | PAK4 | 0.98056383 |
64 | RPS6KB2 | 0.97794320 |
65 | IRAK2 | 0.97634099 |
66 | TESK1 | 0.96279375 |
67 | SGK3 | 0.95744685 |
68 | MARK2 | 0.94723029 |
69 | EIF2AK3 | 0.94639151 |
70 | FLT3 | 0.94564704 |
71 | SIK3 | 0.92505868 |
72 | STK24 | 0.92345840 |
73 | LCK | 0.90351692 |
74 | MATK | 0.89477318 |
75 | CAMK1D | 0.87766969 |
76 | BLK | 0.87515898 |
77 | MAP3K5 | 0.86932883 |
78 | PIK3CA | 0.86767809 |
79 | MST1R | 0.86692310 |
80 | MAP3K13 | 0.86153432 |
81 | ILK | 0.84531775 |
82 | CSF1R | 0.83960008 |
83 | IKBKB | 0.82713328 |
84 | PIM1 | 0.82052534 |
85 | WNK4 | 0.80874615 |
86 | TLK1 | 0.80417924 |
87 | RAF1 | 0.80313046 |
88 | SGK2 | 0.79518351 |
89 | FGFR3 | 0.79215873 |
90 | PDK1 | 0.78916642 |
91 | MYLK | 0.76591084 |
92 | GRK6 | 0.75699520 |
93 | CDK6 | 0.75476775 |
94 | MST4 | 0.73254046 |
95 | MAP3K6 | 0.72564825 |
96 | MAP3K8 | 0.72175921 |
97 | MARK3 | 0.71651807 |
98 | PDPK1 | 0.70204076 |
99 | CSK | 0.69672055 |
100 | TIE1 | 0.69253706 |
101 | BMX | 0.69202464 |
102 | STK39 | 0.69164914 |
103 | KSR1 | 0.68943777 |
104 | SCYL2 | 0.68768854 |
105 | PRKD1 | 0.68714473 |
106 | PRKG2 | 0.67681335 |
107 | FRK | 0.66999694 |
108 | EPHA3 | 0.66392133 |
109 | JAK2 | 0.66176828 |
110 | DYRK3 | 0.65705413 |
111 | STK3 | 0.65109983 |
112 | FER | 0.64927853 |
113 | STK38 | 0.63722864 |
114 | SMG1 | 0.63359174 |
115 | MAPKAPK2 | 0.60370127 |
116 | NME2 | 0.59833101 |
117 | PAK2 | 0.58933758 |
118 | CDK12 | 0.58373098 |
119 | PHKG1 | 0.57918258 |
120 | PHKG2 | 0.57918258 |
121 | MAP2K1 | 0.56846193 |
122 | PRKAA2 | 0.56019748 |
123 | RPS6KA5 | 0.55431062 |
124 | ZAP70 | 0.54501864 |
125 | HIPK2 | 0.54198904 |
126 | MAP3K2 | 0.53996630 |
127 | GSK3A | 0.52948603 |
128 | LIMK1 | 0.52215919 |
129 | EPHB2 | 0.52111764 |
130 | FYN | 0.51709975 |
131 | PDGFRA | 0.51476228 |
132 | FGFR2 | 0.50474063 |
133 | RET | 0.50402042 |
134 | BTK | 0.50084269 |
135 | IRAK3 | 0.49530788 |
136 | ITK | 0.48960820 |
137 | MTOR | 0.48768021 |
138 | EIF2AK1 | 0.48423545 |
139 | PLK2 | 0.48231068 |
140 | RPS6KC1 | 0.47156652 |
141 | RPS6KL1 | 0.47156652 |
142 | LATS1 | 0.46883632 |
143 | WNK1 | 0.45614830 |
144 | CLK1 | 0.44677381 |
145 | MAPK11 | 0.44670658 |
146 | MOS | 0.44278895 |
147 | PDK2 | 0.44073672 |
148 | ERBB2 | 0.43959124 |
149 | RPS6KA6 | 0.43847351 |
150 | JAK3 | 0.43255057 |
151 | JAK1 | 0.42968174 |
152 | MAPK12 | 0.42057000 |
153 | CAMKK2 | 0.40539733 |
154 | SGK494 | 0.37075261 |
155 | SGK223 | 0.37075261 |
156 | PRKD2 | 0.34624599 |
157 | MAP2K4 | 0.34144625 |
158 | NLK | 0.33737174 |
159 | MAP3K7 | 0.31415082 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 3.28090677 |
2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.37970854 |
3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.21685107 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.11658491 |
5 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.02177342 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96516058 |
7 | Tuberculosis_Homo sapiens_hsa05152 | 1.94386586 |
8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83909911 |
9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.80031289 |
10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77114611 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75142157 |
12 | Measles_Homo sapiens_hsa05162 | 1.74126112 |
13 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.72224217 |
14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71707628 |
15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69961201 |
16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69241859 |
17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.67532709 |
18 | Lysosome_Homo sapiens_hsa04142 | 1.64793315 |
19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55663335 |
20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52764551 |
21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50314109 |
22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49945186 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49271353 |
24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47362734 |
25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44007378 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43142623 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.39192270 |
28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38757925 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38346708 |
30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37227682 |
31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36079251 |
32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35001314 |
33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31999334 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31483526 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31187129 |
36 | ABC transporters_Homo sapiens_hsa02010 | 1.30938851 |
37 | Allograft rejection_Homo sapiens_hsa05330 | 1.29568134 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27337638 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27086647 |
40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25336109 |
41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.24894958 |
42 | Insulin resistance_Homo sapiens_hsa04931 | 1.24199885 |
43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.24165599 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.22997326 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.22422331 |
46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21815843 |
47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19967493 |
48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18826446 |
49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18305631 |
50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16973671 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15712552 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15260252 |
53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13343377 |
54 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13091608 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10543996 |
56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10412696 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10329309 |
58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08636034 |
59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08405050 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07240622 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07203164 |
62 | Malaria_Homo sapiens_hsa05144 | 1.06428783 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04792958 |
64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.03823114 |
65 | Focal adhesion_Homo sapiens_hsa04510 | 1.03685338 |
66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02911147 |
67 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02069502 |
68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00329419 |
69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99412934 |
70 | Amoebiasis_Homo sapiens_hsa05146 | 0.99412068 |
71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98021438 |
72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97355118 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97314650 |
74 | Bladder cancer_Homo sapiens_hsa05219 | 0.96692715 |
75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95684274 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95412744 |
77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95408278 |
78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94949294 |
79 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94298456 |
80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93605913 |
81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92906524 |
82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92834109 |
83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92829397 |
84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91668425 |
85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91575045 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91448491 |
87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90649878 |
88 | Peroxisome_Homo sapiens_hsa04146 | 0.90536221 |
89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88721085 |
90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88536586 |
91 | Apoptosis_Homo sapiens_hsa04210 | 0.85254787 |
92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84738529 |
93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84420189 |
94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83414053 |
95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82845080 |
96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82677640 |
97 | Legionellosis_Homo sapiens_hsa05134 | 0.81881988 |
98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81769715 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81537129 |
100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81501525 |
101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80182850 |
102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79422642 |
103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77117102 |
104 | Adherens junction_Homo sapiens_hsa04520 | 0.77012927 |
105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76680109 |
106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76323949 |
107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75531952 |
108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75530842 |
109 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75439278 |
110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73935428 |
111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72686762 |
112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72525551 |
113 | Glioma_Homo sapiens_hsa05214 | 0.70917982 |
114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70588379 |
115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70328248 |
116 | Tight junction_Homo sapiens_hsa04530 | 0.70287282 |
117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69876060 |
118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67257657 |
119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65197680 |
120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64938755 |
121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64889535 |
122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64247676 |
123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63166651 |
124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63157994 |
125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62789519 |
126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62538538 |
127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62176252 |
128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61846671 |
129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61812170 |
130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60885487 |
131 | Prostate cancer_Homo sapiens_hsa05215 | 0.59153790 |
132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58929023 |
133 | Phagosome_Homo sapiens_hsa04145 | 0.58773380 |
134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58019184 |
135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57817597 |
136 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57467695 |
137 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57416494 |
138 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57103694 |
139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56786122 |
140 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56554501 |
141 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56370756 |
142 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56332869 |
143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56058947 |
144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55983899 |
145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55927226 |
146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55430630 |
147 | Pertussis_Homo sapiens_hsa05133 | 0.54877023 |
148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54596743 |
149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54280819 |
150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53570587 |
151 | Salmonella infection_Homo sapiens_hsa05132 | 0.53296452 |
152 | Endocytosis_Homo sapiens_hsa04144 | 0.52097776 |
153 | Platelet activation_Homo sapiens_hsa04611 | 0.51312416 |
154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51010694 |
155 | Shigellosis_Homo sapiens_hsa05131 | 0.51000833 |
156 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50154339 |
157 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49196841 |
158 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47886686 |
159 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47812236 |
160 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47732936 |
161 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46759107 |
162 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46692899 |
163 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46676167 |